Breaking News
DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Curaleaf Presses Forward as Aurora Explores Rival Organigram Offer
STAMFORD – Curaleaf Holdings Inc. issued a pointed statement, acknowledging ...
Medical Cannabis Gets Its Federal Papers
LOS ANGELES – On October 30, the U.S. Department of ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Optimi Goes Down Under with New Australian Subsidiary
VANCOUVER / SYDNEY – Optimi Health Corp., a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, announced the establishment of Optimi Australia Pty Ltd, a wholly owned subsidiary responsible for distribution and business ...
Cannabis Buyers Are Price-Sensitive, Now The Federal Data Proves It
LOS ANGELES – The study, published this month in the peer-reviewed journal Addiction, was conducted by researchers at the University of California San Diego and received funding from the National Institute on Drug Abuse (NIDA) ...
Argent BioPharma Licenses Proprietary Cannabis Genetics in Global Thai Phytomed Agreement
LONDON / PERTH – Argent BioPharma Ltd. has signed a decade-long exclusive worldwide licensing agreement with Thai Phytomed International (TPI), covering four proprietary Cannabis genotypes developed within the Argent group over several years. Under the ...
